Literature DB >> 1714094

Immunogenicity of foreign peptide epitopes expressed in bacterial envelope proteins.

D O'Callaghan1, A Charbit, P Martineau, C Leclerc, S van der Werf, C Nauciel, M Hofnung.   

Abstract

We have used two bacterial proteins from Escherichia coli to express heterologous peptides. Both proteins are situated in the E. coli cell envelope but have different properties: LamB is an integral outer membrane protein, and MalE a soluble periplasmic protein. The peptides were expressed as genetic inserts within "permissive sites" of these recipient proteins, i.e. sites which allow the insertion of foreign peptides without affecting the biological properties of the host protein. In this paper, we summarize preliminary rules governing the immunogenicity of resulting LamB and MalE hybrid proteins when expressed in E. coli. We focus on two model epitopes: either peptide 132-145 from the preS(2) region of hepatitis B virus or peptide 93-103 from poliovirus VP1 capsid protein. We also present first results obtained when the same hybrid proteins were expressed in attenuated Salmonella typhimurium. Plasmids encoding the hybrid proteins were transferred to aroA S.typhimurium by electroporation. In vitro, the hybrid proteins could be expressed at high levels by S. typhimurium. Mice were immunized by parenteral and oral routes. The effect of the carrier protein and the level of its expression on the in vivo behaviour of the immunizing bacteria and on the immune response induced will be discussed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1714094     DOI: 10.1016/0923-2508(90)90136-e

Source DB:  PubMed          Journal:  Res Microbiol        ISSN: 0923-2508            Impact factor:   3.992


  8 in total

1.  Infectious enveloped RNA virus antigenic chimeras.

Authors:  S D London; A L Schmaljohn; J M Dalrymple; C M Rice
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-01       Impact factor: 11.205

Review 2.  Recombinant avirulent salmonellae as oral vaccine carriers.

Authors:  F Schödel
Journal:  Infection       Date:  1992 Jan-Feb       Impact factor: 3.553

3.  Molecular and cellular targeting in the expression of foreign polypeptides in bacteria.

Authors:  J M Clément; A Charbit; C Leclerc; P Martineau; S Muir; D O'Callaghan; O Popescu; S Szmelcman; M Hofnung
Journal:  Antonie Van Leeuwenhoek       Date:  1992-02       Impact factor: 2.271

4.  Expression of recombinant proteins on the surface of the coagulase-negative bacterium Staphylococcus xylosus.

Authors:  M Hansson; S Ståhl; T N Nguyen; T Bächi; A Robert; H Binz; A Sjölander; M Uhlén
Journal:  J Bacteriol       Date:  1992-07       Impact factor: 3.490

5.  Immunogenicity of IpaC-hybrid proteins expressed in the Shigella flexneri 2a vaccine candidate SC602.

Authors:  S Bârzu; J Arondel; S Guillot; P J Sansonetti; A Phalipon
Journal:  Infect Immun       Date:  1998-01       Impact factor: 3.441

6.  Compartmentalization of defined epitopes expressed in Escherichia coli has only a minor influence on efficiency of phagocytic processing for presentation by class I and class II major histocompatibility complex molecules to T cells.

Authors:  M J Wick; J D Pfeifer; K A Findlay; C V Harding; S J Normark
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

7.  Infectious Sindbis virus transient expression vectors for studying antigen processing and presentation.

Authors:  C S Hahn; Y S Hahn; T J Braciale; C M Rice
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

Review 8.  Vaccination of adults against travel-related infectious diseases, and new developments in vaccines.

Authors:  P C Döller
Journal:  Infection       Date:  1993 Jan-Feb       Impact factor: 3.553

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.